Head-To-Head Review: Moolec Science (NASDAQ:MLEC) & Corteva (NYSE:CTVA)

Moolec Science (NASDAQ:MLEC) and Corteva (NYSE:CTVA) are both consumer staples companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, valuation, risk, profitability and institutional ownership.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Moolec Science and Corteva, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Moolec Science	0	0	0	0	0.00
Corteva	0	9	14	0	2.61

Corteva has a consensus price target of $84.52, indicating a potential upside of 5.08%. Given Corteva’s stronger consensus rating and higher possible upside, analysts plainly believe Corteva is more favorable than Moolec Science.

Institutional and Insider Ownership

0.1% of Moolec Science shares are held by institutional investors. Comparatively, 81.5% of Corteva shares are held by institutional investors. 19.9% of Moolec Science shares are held by company insiders. Comparatively, 0.2% of Corteva shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares Moolec Science and Corteva’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Moolec Science	N/A	N/A	N/A
Corteva	6.29%	9.06%	5.39%

Risk and Volatility

Moolec Science has a beta of -0.36, suggesting that its share price is 136% less volatile than the S&P 500. Comparatively, Corteva has a beta of 0.68, suggesting that its share price is 32% less volatile than the S&P 500.

Earnings and Valuation

This table compares Moolec Science and Corteva”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Moolec Science	$333.61 million	0.02	-$111.46 million	($33.00)	-0.22
Corteva	$17.40 billion	3.10	$1.09 billion	$1.58	50.91

Corteva has higher revenue and earnings than Moolec Science. Moolec Science is trading at a lower price-to-earnings ratio than Corteva, indicating that it is currently the more affordable of the two stocks.

Summary

Corteva beats Moolec Science on 13 of the 14 factors compared between the two stocks.

About Moolec Science

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.

About Corteva

Corteva, Inc. operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was incorporated in 2018 and is headquartered in Indianapolis, Indiana.